| Application no. and date | 22173763.8 (espacenet) (Federated) (European Patent Register), 20111003 | | Patent/reg. no. and date | DK/EP 4108671, 20241120 | | Publication date | 20221228 | | Priority no. and date | US 40441310 P, 20101001 | | EP pub. no. and date |
EP 4108671 20221228 | | Effective date | | | Applicant/owner | ModernaTX, Inc., 325 Binney Street
Cambridge, MA 02142, US | | Applicant ref. no. | 170692 SH/SD | | Inventor | Siddiqi, Suhaib,
Burlington, MA 01803, US,
Schrum, Jason P,
Watertown, MA 02472-2580, US,
Ejebe, Kenechi,
New York, NY 10029, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/7115 (2006.01) , C07H 19/10 (2006.01) , C07H 21/02 (2006.01) , C12N 15/11 (2006.01) | | Title | MODIFICEREDE NUKLEOSIDER, NUKLEOTIDER OG NUKLEINSYRER SAMT ANVENDELSER DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
